Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Former GE Healthcare LATAM Head Joins Brazil-Focused Adavium

This article was originally published in Clinica

Executive Summary

Adavium Medical, a company focused on selling medical devices and diagnostics in Brazil, has appointed Claudia Goulart chief operating officer and president of its diagnostics division. Goulart, who has been a board member of Adavium since 2013, was the former CEO of GE Healthcare for Latin America. She has also held senior leadership roles in a number of private equity-backed companies. Adavium was founded in 2011 and partners with other medtech companies to help them navigate the Brazilian market and commercialize their products in the country. It has expanded its operations over the years through the acquisitions of Brazilian medtech companies; the appointment of Goulart follows the company’s announcement of two more acquisitions, diagnostics firms Alka Tecnologia and Hemogram Industria e Comercio, thus making Adavium the largest Brazilian medical device and clinical diagnostic provider.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT103329

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel